DEFB131B
Beta-defensin 131B
Also known as: D131B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A096LNP1
- Gene
- DEFB131B
- Ensembl
- ENSG00000225805
- Chromosome
- 11
- Canonical length
- 70 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Predicted to be involved in defense response to bacterium and innate immune response. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
70 residues, UniProt reviewed canonical sequence.
>A0A096LNP1|DEFB131B
1 MRVLFFVFGV LSLMSTVPPT RSFTSNDECP SEYYHCRLKC NADEHAIRYC ADFSICCKLK
61 IIQIDGQKKWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DEFB131B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 57 nTPM
- gallbladder: 0.8 nTPM
- thyroid gland: 0.7 nTPM
- retina: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- duodenum: 0.3 nTPM
Single-cell type
- epididymal principal cells: 40 nCPM
- epicardial cells: 11 nCPM
- retinal ganglion cells: 7.7 nCPM
- adipocytes: 6.3 nCPM
- cardiomyocytes: 4.5 nCPM
- fibro-adipogenic progenitors: 3.9 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- midbrain: 3.5 nTPM
- cerebral cortex: 3.2 nTPM
- amygdala: 2.3 nTPM
- hypothalamus: 2.3 nTPM
- thalamus: 2.3 nTPM
- white matter: 2.3 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DEFB131B as an antibody target. Whether an autoantibody or antibody against DEFB131B could matter depends on whether native DEFB131B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DEFB131B is annotated as secreted, so native DEFB131B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DEFB131B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...